CoChat

Role of insulin resistance in endothelial dysfunction

Open access
Muniyappa, Ranganath, Sowers, James R. · 2013 · Reviews in Endocrine and Metabolic Disorders

The DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.

Abstract

Insulin resistance is frequently associated with endothelial dysfunction and has been proposed to play a major role in cardiovascular diseases. Insulin exerts pro- and anti-atherogenic actions on the vasculature. The balance between nitric oxide (NO)-dependent vasodilator actions and endothelin-1- dependent vasoconstrictor actions of insulin is regulated by phosphatidylinositol 3-kinase-dependent (PI3K) - and mitogen-activated protein kinase (MAPK)-dependent signaling in vascular endothelium, respectively. During insulin-resistant conditions, pathway-specific impairment in PI3K-dependent signaling may cause imbalance between production of NO and secretion of endothelin-1 and lead to endothelial dysfunction. Insulin sensitizers that target pathway-selective impairment in insulin signaling are known to improve endothelial dysfunction. In this review, we discuss the cellular mechanisms in the endothelium underlying vascular actions of insulin, the role of insulin resistance in mediating endothelial dysfunction, and the effect of insulin sensitizers in restoring the balance in pro- and anti-atherogenic actions of insulin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11154-012-9229-1

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 80 references

Cited by

See all 579

Metadata

Authors
Muniyappa, R., & Sowers, J. R.
Affiliations
  • National Institutes of Health (US)
  • Harry S. Truman Memorial Veterans' Hospital (US)
Corresponding author
Sowers, James R.
Venue
Reviews in Endocrine and Metabolic Disorders
Published
2013-01-10
Volume
14
Issue
1
Pages
5-12
ISSN
  • 1389-9155 (ISSN-L)
  • 1573-2606
OpenAlex
W1975628529
Cited by
539
References
81
Citations by year
2026: 60 · 2025: 62 · 2024: 57 · 2023: 30 · 2022: 41 · 2021: 36 · 2020: 52 · 2019: 38 · 2018: 47 · 2017: 28 · 2016: 25 · 2015: 29 · 2014: 21 · 2013: 13
FWCI
3.23
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Reviews in Endocrine and Metabolic Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Veterans Affairs
  • National Institutes of Health (5r01hl107910-03)
  • National Heart, Lung, and Blood Institute (R01 HL107910-03, R01-HL-107910, R01HL073101, R01 HL73101-08)
  • National Institute of Diabetes and Digestive and Kidney Diseases
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
insulin resistance, endothelial dysfunction, insulin signaling, nitric oxide, endothelin-1, PI3K signaling, MAPK signaling, insulin sensitizers, atherosclerosis, vascular endothelium, cardiovascular disease
MeSH terms
Animals, Endothelium, Vascular, Humans, Insulin Resistance, Nitric Oxide, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of insulin resistance in endothelial dysfunction. https://app.cochat.ai/papers/10.1007/s11154-012-9229-1
The paper
Muniyappa, R., & Sowers, J. R. (2013). Role of insulin resistance in endothelial dysfunction. Reviews in Endocrine and Metabolic Disorders. https://doi.org/10.1007/s11154-012-9229-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.